Ewg Elevate Inc. Nektar Therapeutics Transaction History

Ewg Elevate Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 07, 2020	SELL	$16.86 - $23.44 $380,968 - $529,650	-22,596 Closed	0 $0
Q1 2020 Apr 15, 2020	BUY	$14.47 - $27.96 $72,002 - $139,128	4,976 Added 28.24%	22,596 $403,000
Q4 2019 Jan 28, 2020	BUY	$15.87 - $23.12 $279,629 - $407,374	17,620 New	17,620 $380,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $171M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Ewg Elevate Inc., based on Form 13F filings with the SEC.

Stay updated on Ewg Elevate Inc. with notifications on news.